Spots Global Cancer Trial Database for ovarian neoplasm epithelial
Every month we try and update this database with for ovarian neoplasm epithelial cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Bortezomib and Pegylated Liposomal Doxorubicin in BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer Patients | NCT03509246 | Ovarian Neoplas... High Grade Sero... | Pegylated lipos... | 19 Years - | Seoul National University Hospital | |
| Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival | NCT04402333 | Ovarian Cancer Ovarian Neoplas... Ovarian Neoplas... Fallopian Tube ... Peritoneal Canc... | Robotic Interva... | 18 Years - | Royal Surrey County Hospital NHS Foundation Trust | |
| Sub-type Specific Genomic Mutations in sBOTs | NCT03883542 | Ovarian Neoplas... | genomic mutatio... | 18 Years - | Universitair Ziekenhuis Brussel | |
| MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) | NCT04111978 | Ovarian Neoplas... Fallopian Tube ... Peritoneal Neop... High-grade Sero... Low-grade Serou... Ovarian Endomet... | Letrozole 2.5mg Placebo | 18 Years - | Swiss GO Trial Group | |
| Bortezomib and Pegylated Liposomal Doxorubicin in BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer Patients | NCT03509246 | Ovarian Neoplas... High Grade Sero... | Pegylated lipos... | 19 Years - | Seoul National University Hospital | |
| Inherited Susceptible Genes Among Epithelial Ovarian Cancer | NCT03015376 | Ovarian Neoplas... Hereditary Brea... | - | Peking Union Medical College Hospital | ||
| Functional Analysis of BRCAness | NCT04780945 | Ovarian Neoplas... Homologous Reco... BRCA1 Mutation BRCA2 Mutation | Functional RAD5... Olaparib Oral P... | 18 Years - | Leiden University Medical Center | |
| MIRRORS-RCT Pilot: Role of Robotic Interval Cytoreductive Surgery for Advanced Ovarian Cancer | NCT05960630 | Ovarian Cancer Ovarian Neoplas... Ovarian Neoplas... Fallopian Tube ... Fallopian Tube ... Peritoneal Canc... | MIRRORS Protoco... Standard Open C... | 18 Years - | Royal Surrey County Hospital NHS Foundation Trust | |
| Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer | NCT05605535 | Ovarian Neoplas... Ovarian Cancer Fallopian Tube ... Peritoneal Carc... Ovarian Serous ... | Oregovomab Paclitaxel Carboplatin Placebo | 18 Years - | CanariaBio Inc. | |
| Sub-type Specific Genomic Mutations in sBOTs | NCT03883542 | Ovarian Neoplas... | genomic mutatio... | 18 Years - | Universitair Ziekenhuis Brussel | |
| MIRRORS-RCT Pilot: Role of Robotic Interval Cytoreductive Surgery for Advanced Ovarian Cancer | NCT05960630 | Ovarian Cancer Ovarian Neoplas... Ovarian Neoplas... Fallopian Tube ... Fallopian Tube ... Peritoneal Canc... | MIRRORS Protoco... Standard Open C... | 18 Years - | Royal Surrey County Hospital NHS Foundation Trust | |
| A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) | NCT05001282 | Ovarian Cancer Ovarian Neoplas... Ovarian Carcino... Endometrial Can... Ovary Cancer Ovary Neoplasm Ovary Disease Ovary Metastasi... Ovarian Disease... Ovarian Cancer ... Ovarian Epithel... Ovarian Adenoca... Ovarian Serous ... Ovarian Neoplas... Ovarian Cancer ... Endometrial Dis... Endometrial Ade... Endometrial Car... Endometrial Cle... Endometrioid Ad... Endometrial Neo... Endometrial Can... Endometrioid Tu... Fallopian Tube ... Peritoneal Canc... | ELU001 | 18 Years - | Elucida Oncology | |
| Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer | NCT05605535 | Ovarian Neoplas... Ovarian Cancer Fallopian Tube ... Peritoneal Carc... Ovarian Serous ... | Oregovomab Paclitaxel Carboplatin Placebo | 18 Years - | CanariaBio Inc. | |
| Bortezomib and Pegylated Liposomal Doxorubicin in BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer Patients | NCT03509246 | Ovarian Neoplas... High Grade Sero... | Pegylated lipos... | 19 Years - | Seoul National University Hospital | |
| Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival | NCT04402333 | Ovarian Cancer Ovarian Neoplas... Ovarian Neoplas... Fallopian Tube ... Peritoneal Canc... | Robotic Interva... | 18 Years - | Royal Surrey County Hospital NHS Foundation Trust |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
